Why the study?
Although guideline-directed medical therapies reduce mortality and hospitalizations in heart failure, medication non-adherence remains a critical barrier limiting real-world efficacy.
This ESC/HFA scientific statement provides a comprehensive framework for understanding and addressing medication non-adherence in heart failure management.
Answers are grounded in this paper and cite their sources.
Provides framework to overcome non-adherence limiting GDMT efficacy in HF; extends prior guidelines with standardized measurement and intervention strategies.
Heart failure (HF) affects over 60 million individuals globally. Contemporary guideline-directed medical therapies (GDMT) reduce cardiovascular mortality and HF hospitalizations. However, medication non-adherence represents a critical barrier limiting real-world efficacy of GDMT. This scientific statement aims to provide a comprehensive framework for understanding, measuring, and addressing medication non-adherence in HF management across diverse healthcare settings. Addressing medication non-adherence requires systematic, multifaceted approaches targeting individual patient barriers while implementing system-level interventions. Polypills, digital monitoring platforms, enhanced patient education and empowerment, and multidisciplinary care models represent promising strategies to optimize therapeutic adherence and improve clinical outcomes in HF management.
No takes yet. Share an insight, caveat, or question.
Savarese et al. (2025) conducted a review in Heart failure. Multifaceted adherence strategies was evaluated. Systematic, multifaceted approaches including polypills, digital monitoring, and multidisciplinary care models represent promising strategies to optimize therapeutic adherence in heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: